T 0402/12 (Neoadjuvant therapy/GENENTECH) of 17.03.2016
- European Case Law Identifier
- ECLI:EP:BA:2016:T040212.20160317
- Date of decision
- 17 March 2016
- Case number
- T 0402/12
- Petition for review of
- -
- Application number
- 00928916.6
- IPC class
- A61P 35/00A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment with anti-ErbB2 antibodies
- Applicant name
- Genentech, Inc.
- Opponent name
- Teva Pharmaceutical Industries Ltd.
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 115European Patent Convention Art 56
- Keywords
- Inventive step - main request (no)
Inventive step - auxiliary request (no)
Observations by third parties - relevant (no) - Catchword
- -
- Cited cases
- T 1756/11
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed